As a significant breakthrough in rare disease therapy, the U.S. Food and Drug Administration (FDA) has just approved Andembry (garadacimab‑gxii), the first-ever prophylactic treatment that aims for ...
Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...
JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine ...